Jane M. Pruemer - Concepedia

Author

Jane M. Pruemer

University of Cincinnati Medical Center ORCID

Also Known As

J M Pruemer, J Pruemer, J. Pruemer, Jane M Pruemer, Jane M. Pruemer, Jane Pruemer

Publications

443

Citations

H-Index

Concepts

All Affiliations

University of Cincinnati Medical Center University of Cincinnati The University of Texas MD Anderson Cancer Center

About

Jane M. Pruemer is an author at University of Cincinnati Medical Center specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	173
2	Natural Sciences	2	2	29
3	Biochemistry	2	2	29
4	Health Sciences	1	1	11
5	Nursing	1	1	10

Jane M. Pruemer

Publications

337

Citations

H-Index

Page 1

	Year	Citations
Preventing medication errors in cancer chemotherapy Michael R. Cohen, Roger W. Anderson, Richard M. Attilio, American Journal of Health-System Pharmacy Drug SafetyTherapeutic Drug MonitoringPreprinted Order FormsMedicineDrug Information System	1996	123
Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014 Xiaomeng Yue, Jane M. Pruemer, Ana L. Hincapie, Journal of Gynecologic Oncology	2020	46
Symptom Management Needs of Oncology Outpatients Kyra M. Whitmer, Jane M. Pruemer, Zeina Nahleh, Journal of Palliative Medicine	2006	42
Melatonin, a Promising Role in Taxane-Related Neuropathy Zeina Nahleh, Jane M. Pruemer, Jennifer Ann LaFollette, Clinical Medicine Insights Oncology	2010	40
Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura Jane M. Pruemer American Journal of Health-System Pharmacy	2009	15
Liquid-chromatographic monitoring of cytosine arabinoside and its metabolite, uracil arabinoside, in serum. Joseph R. Wermeling, Jane M. Pruemer, ⁠Faez M. Hassan, Clinical Chemistry Pharmaceutical ScienceAmmonium AcetateGlycobiologyPharmacotherapyPharmaceutical Chemistry	1989	15
Liquid-chromatographic monitoring of cytosine arabinoside and its metabolite, uracil arabinoside, in serum. Joseph R. Wermeling, Jane M. Pruemer, ⁠Faez M. Hassan, PubMed Ammonium AcetateGlycobiologyPharmacotherapyPharmaceutical ChemistryMedicinal Chemistry	1989	14
Thromboembolic Events in Patients With Colorectal Cancer Receiving the Combination of Bevacizumab-Based Chemotherapy and Erythropoietin Stimulating Agents Julianna Roddy, Suzanne M. Partridge, Michelle Rockey, American Journal of Clinical Oncology	2010	11
Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience Nagla Fawzy Abdel Karim, Rammey Hassan, Nabeela Iffat Siddiqi, Journal of International Medical Research Cancer ManagementPharmacotherapySystematic Computational DrugTricyclic AntidepressantsMetronomic Therapy	2019	11
Development of an Outpatient Oncology Symptom Management Clinic Kyra Whitmer, Jane M. Pruemer, Cheryl Wilhelm, Clinical journal of oncology nursing Palliative CareNursingPrimary CarePatient ExperiencePatient Safety	2011	10

Page 1